 0. Differentiate safety, efficacy, pharmacokinetics (PK), and adherence data for the agents used in the long-term maintenance of schizophrenia. 0. Discuss healthcare decision-making and motivation among schizophrenia patients and healthcare providers. 0. Recommend interventions to HCPs that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs. 0. Perform interventions for schizophrenia patients that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs. 0. Differentiate safety, efficacy, pharmacokinetics (PK), and adherence data for the agents used in the long-term maintenance of schizophrenia. 0. Discuss healthcare decision-making and motivation among schizophrenia patients and healthcare providers. 0. Recommend interventions to HCPs that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs. 0. Perform interventions for schizophrenia patients that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs. 